Blog

Article of the Day, August 25th, suggested by IMMONC

Photo taken from Immune Oncology Research Institute/LinkedIn

Aug 26, 2024, 04:06

Article of the Day, August 25th, suggested by IMMONC

Immune Oncology Research Institute made the following post on LinkedIn:

“Article of the day suggested by the Immune Oncology Research Institute.
Author Affiliations: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University – The Feinberg School of Medicine.″

Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis

Authors: Anthony V. Serritella, MD, Niraj K. Shenoy, MD, PhD, MS.

Source: Immune Oncology Research Institute/LinkedIn

advanced cancers Anthony V. Serritella cancer Cancer research cancer treatment Feinberg School of Medicine Immune Oncology Research Institute ipilimumab melanoma research meta-analysis Niraj K. Shenoy nivolumab Northwestern University OncoDaily Oncology oncology study Robert H. Lurie Comprehensive Cancer Center

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage